We Value Your Privacy
We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies.
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
No cookies to display.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
No cookies to display.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
No cookies to display.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
No cookies to display.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
No cookies to display.
Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.
Since 2013, Federal regulators have stepped up scrutiny of the relationships between pharmaceutical manufacturers and healthcare providers. Considering the potential fines that are in place, this isn’t a time when companies can sit back complacently. Instead, they must dedicate this time to verifying the accuracy of their data and reporting systems so they can identify […]
Government agencies are increasingly using publicly available data sets in support of their allegations against pharmaceutical and device manufacturing companies. A recent example is the government’s allegation of kickbacks against Insys Therapeutics, Inc. and their use of both Open payments and Medicare Part D data. Managing the Risk of Open Payments Data CMS published the […]
Pharma manufacturers, for the very first time, are revealing how much they have spent on HCOs and HCPs . By 30th June 2016, all pharma manufacturers will be required to publish payments made to healthcare professionals. Pharma manufacturers have made mistakes in the past, but these are evolving rapidly. Non-duplication of data is one major […]
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 2024. All rights reserved | Sitemap | Privacy Policy | Terms of Use